Although patients and their families always anticipate a favorable outcome, multiple gestations are high-risk pregnancies. Common obstetric complications such as preeclampsia, gestational diabetes, preterm labor, and intrauterine fetal growth restriction occur more frequently in multiple gestations, however their management remains essentially the same as it would be for a singleton pregnancy. In contrast, unique challenges arise when one fetus in a multiple gestation has an abnormality, suffers an intrauterine demise, experiences preterm premature rupture of the membranes, or delivers prematurely. The presence of more than one fetus in utero confounds the diagnosis and management of these serious obstetric complications.
An Abnormality Affecting One Fetus
Both chromosomal and structural abnormalities may affect one fetus a multiple gestation. With increasing maternal age and widespread use of assisted reproduction, the number of twins and higher-order multiples in older women at risk for fetal chromosomal abnormalities has risen. In addition, each fetus in a multiple gestation has its own risk for structural abnormalities so that the overall risk for the pregnancy increases with the number of fetuses. The goals of prenatal diagnosis in multiple gestations are the same as for singletons: to identify fetal abnormalities that could lead to a couple's decision to terminate a pregnancy, to alter the management of continuing pregnancies, and to identify fetuses that might benefit from fetal or early neonatal therapy. However, prenatal diagnosis in multiple gestations poses a number of unique issues. Maternal serum screening is not as useful in twins and may not be interpretable in higher-order multiples. Invasive diagnostic procedures, such as chorionic villus sampling and amniocentesis, are technically more challenging in multiple gestations. The presence of multiple fetuses makes the assessment of fetal anatomy at the time of prenatal ultrasound more difficult. Furthermore, the diagnosis of an abnormal fetus creates a complex set of circumstances for a family that must decide between pregnancy termination, expectant management, or selective fetal reduction.
PRENATAL DIAGNOSIS AND ISSUES PARTICULAR TO MULTIPLES
Counseling and management of any multiple gestation requires an accurate assessment of chorionicity. Knowing the chorionicity affects counseling regarding the risk of aneuploidy, decisions regarding invasive diagnostic testing, and when desired, options for fetal reduction. Chorionicity can be determined most reliably by the identification of separate placentae or by identifying the lambda or twin-peak sign in the first trimester, a sonographic finding less reliable later in pregnancy. In the second trimester, incorrect characterization of chorionicity by ultrasound occurs in 10% to 12% of multiple gestations. 1 For a monozygotic twin gestation in which both fetuses have the same karyotype, the risk of fetal aneuploidy is identical to the age-related risk for a singleton pregnancy. This excludes the rare cases of post-division mitotic nondisjunction in one twin. Although this rare event should not affect the calculation of aneuploidy risk, it does necessitate the sampling of both fetuses in a monozygotic pair when performing genetic testing. Dizygotic twin pregnancies have different karyotypes and therefore each fetus has an independent aneuploidy risk. Thus, while the probability of both fetuses being affected is small, the risk of having at least one affected fetus is doubled. Similarly, the risk of aneuploidy in higherorder gestations is based on the number of fetuses and assumes unique chorionicity for each fetus. However, recent studies have shown that monozygosity occurs in 9.8% of multiple gestations achieved by assisted reproductive technology. 2 Unfortunately, zygosity is often not known at the time of initial genetic counseling and an estimate of risk may be made by assuming that about 1/3 of twin pregnancies are monozygotic and 2/3 are dizygotic. Although this ratio may vary slightly depending on the ethnicity and age of the woman, the approximate risk of at least one aneuploid fetus is 5/3 the risk of an age specific singleton pregnancy. 3 Based on these calculations, a 31-year-old woman with twins of unknown zygosity has the same risk of having at least one aneuploid fetus as a 35-year-old woman with a singleton pregnancy (about 1 in 270 in the midtrimester). 3 
FIRST AND SECOND TRIMESTER SCREENING IN MULTIPLES
Maternal serum screening in a multiple gestation is less accurate than in a singleton because altered serum levels from an affected fetus will be brought closer to the mean by the presence of unaffected fetuses. The levels of maternal serum biochemical markers are on average twice as high in twin gestations as in singletons at the same gestational age. 4 However, studies have shown that first trimester beta human chorionic gonadotrophin (␤-HCG) levels are increased 21% in singleton pregnancies resulting from assisted reproduction. 5 Although this finding has not been confirmed in multiple gestations, it may be significant given the large proportion of multiple gestations conceived through assisted reproductive techniques. An enlarged nuchal translucency measurement combined with maternal age has been shown to identify almost 80% of fetuses with trisomy 21 in singleton pregnancies. 6 To date, only one series has evaluated the sensitivity of nuchal translucency measurement for aneuploidy in twins. 7 Of 448 sets of twins that underwent first trimester sonographic screening between 10 and 14 weeks gestation, 7.2% had nuchal translucency measurements that were greater than the 95 th percentile for gestational age. In this series, 7 of 8 fetuses with trisomy 21 were detected by nuchal translucency screening, resulting in a sensitivity of 88%. 7 While the exact sensitivity of nuchal translucency measurement for aneuploidy in twin and higher-order gestations cannot be determined due to small numbers and limited data, these results are comparable to the sensitivity reported for singleton pregnancies. However, there was a false positive rate of 7.3% associated with nuchal translucency screening in twins with a higher incidence of chromosomally normal fetuses in screen positive monochorionic pregnancies (8.4%) compared with dichorionic pregnancies (5.4%). 7 It has been theorized that the increased fetal nuchal translucency measurements in monochorionic pregnancies might be an early manifestation of subtle twin-totwin perfusion imbalances. One possible advantage to screening with nuchal translucency in multiple gestations is that if one fetus is found to be chromosomally abnormal, the increased nuchal translucency measurement can serve as a sonographic marker, along with previous in utero mapping, to assist with identification of the abnormal fetus should the parents later choose selective reduction.
First trimester screening by fetal nuchal translucency thickness combined with maternal serum free ␤-HCG and pregnancyassociated plasma protein-A has been shown in retrospective and prospective studies to identify approximately 90% of cases of trisomy 21 in singleton pregnancies with a 5% false positive rate. 8 This same approach in twin pregnancies has been predicted to identify 80% of cases of twins discordant for trisomy 21 with the same 5% false positive rate. 8 In a single study of 206 twins that had nuchal translucency measurements combined with serum screening in the first trimester, 3 of the 4 cases with trisomy 21 were detected with a false positive rate of 9%. 8 The combination of nuchal translucency measurement and serum screening in multiple gestations may prove to give detection rates similar to those achieved in singleton pregnancies but additional prospective studies are needed.
Second trimester maternal serum screening in twins and higher-order multiples is also limited and still under investigation. As in the first trimester, midtrimester maternal serum biochemical markers in twins are on average double the value seen in singleton pregnancies of the same gestational age. A meta-analysis of eight published studies showed that the median serum levels for twins relative to singleton pregnancies at the same gestational age were 2.26 for alphafetoprotein, 2.06 for ␤-HCG, and 1.68 for unconjugated estriol. 9 The risk of fetal trisomy 21 can be calculated by dividing maternal serum levels by the twin median levels and applying the singleton algorithm. This approach leads to similar false positive rates in twins and singletons, however, the detection rates were 15% lower in twin pregnancies. 10 Again, the lower detection rates are likely due to the normalizing contributions of the unaffected co-twin.
The use of maternal serum alphafetoprotein (MSAFP) to detect structural anomalies such as neural tube defects in twin gestations is also controversial. Applying the singleton standard of 2.5 multiples of the median to a twin gestation would identify 99% of anencephalic fetuses and 89% of open neural tube defects, however, this cutoff would result in an unacceptably high false-positive rate of 30%. 11 Currently most centers use a cut-off of 4.0 multiples of the median for twins, which identifies 60% of open neural tube defects with an 8% falsepositive rate. 11 When one fetus is found to have an open neural tube defect, there is a 2% to 3% chance of a similar defect in the co-twin so thorough sonographic evaluation of both fetuses is indicated. While amniotic fluid alpha-fetoprotein and acetylcholinesterase levels are independent in dichorionic pregnancies, these markers have been shown to diffuse across the thinner dividing membranes of monochorionic twins. 12 The interpretation of MSAFP is also limited in preg-
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nancies that have undergone multifetal pregnancy reduction. Several studies have found that midtrimester MSAFP levels are elevated following multifetal pregnancy reduction, however, ␤-HCG and unconjugated estriol levels are not affected. 13 The increase in maternal serum alpha-fetoprotein is directly related to the number of fetuses reduced and persists for up to 12 weeks.
14 As a result, maternal serum alpha-fetoprotein levels are not recommended for screening patients who have undergone multifetal pregnancy reduction. Both first and second trimester maternal serum screening in multiple gestations remains controversial and warrants further investigation with prospective studies. At the present time, screening in multiples can only be recommended for patients who have received sufficient counseling about the limitations of these tests and available options if abnormal results are obtained.
The majority of fetal structural abnormalities are detected at the time of routine prenatal ultrasound in the second trimester. The accuracy of prenatal ultrasound to detect fetal structural abnormalities is heavily dependent on the expertise of the ultrasonographer. Many twin gestations and most higher-order multiples will be cared for at tertiary care centers with accredited ultrasound units and as a result, a high proportion of major structural anomalies in multiple gestations will be detected. However, adequate visualization of fetal anatomy becomes more challenging as the number of fetuses increase. As with singleton gestations, fetal karyotyping is recommended when major anomalies are identified prenatally.
DIAGNOSTIC PROCEDURES
Counseling about diagnostic procedures in multiple gestations should include a discussion of the risks associated with the procedure and the probability of abnormal results. Each procedure has a risk of pregnancy loss that should be considered in the context of the increased spontaneous loss rates experienced in unsampled multiples. For example, the risk of pregnancy loss in unsampled twins before 28 weeks after a normal second trimester ultrasound is 5%. 15 Furthermore, invasive procedures are technically more complex in multiples and have the possibility of sampling errors and inconclusive results. Any decision to undergo prenatal diagnostic testing should take into account the gestational age of the pregnancy, the level of risk associated with the procedure, and how the patient may wish to proceed in the event of an abnormal result.
Second trimester amniocentesis and first trimester chorionic villus sampling (CVS) are the standard techniques for obtaining fetal cells for karyotyping. Amniocentesis has been shown to be a safe and accurate procedure for prenatal diagnosis in multiples when performed between 15 and 20 weeks. As with CVS, accurate mapping of each fetus and its placenta is essential in the event that discordant results are obtained and selective reduction is to be considered. The technique most commonly used for amniocentesis in multiples is performed under continuous ultrasound guidance, and involves marking the amniotic fluid with dye after a sample is obtained. A new needle is used to sample each additional sac in succession and obtaining dye-free fluid ensures that the sample is not from a previously sampled sac. The most frequently used dye is indigo carmine following reports of fetal small bowel obstruction with midtrimester exposure to methylene blue. 16 Some experts have advocated dye-free sampling techniques that rely on ultrasound guidance to ensure that each sac is sampled separately. 17 However, since inadvertent resampling has been shown to occur in 3.5% of amniocentesis using intraamniotic dye, the use of techniques that cannot confirm sampling of separate sacs is not recommended. 18 Although there have been several studies that have evaluated the risk of second trimester amniocentesis in twin gestations, the results have been conflicting. In a large, retrospective cohort study, Yukobowich et al compared the outcomes of 3 groups: 476 women with twins undergoing amniocentesis, 489 women with singleton gestations undergoing amniocentesis, and 477 women with twins who were unsampled. 19 The incidence of spontaneous abortion within 4 weeks of the procedure was 2.73% in the group of twins that underwent amniocentesis, which was significantly higher than the 0.63% in the unsampled twins and 0.6% in the singletons that underwent amniocentesis. 19 The use of amniocentesis prior to 14 weeks has been described in twins, however, the association of early amniocentesis with a higher pregnancy loss rate, a significant increase in the incidence of musculoskeletal foot deformities, a significantly increased culture failure rate, and an increased rate of fluid leakage in singletons suggests that this procedure should not be routinely used in singleton or multiple pregnancies. 20 In singleton gestations, CVS has been shown to be accurate and safe for first trimester prenatal diagnosis. CVS is performed between 10 and 13 weeks and has the advantage of reassuring patients earlier in the pregnancy when normal results are obtained. In addition, when the CVS results are abnormal, patients are able to make decisions regarding pregnancy termination or selective fetal reduction at a time when termination is safer and the pregnancy more confidential. Performing CVS in a multiple gestation is technically more challenging than second trimester amniocentesis, and requires a sonographer and operator experienced in both the transvaginal and transabdominal approaches. Despite the technical difficulties, CVS is usually successful with sufficient samples being obtained in 99% of twin gestations. 21 One of the major concerns with CVS is that there is no marker to ensure that each placenta is sampled separately. Sampling errors, in which the same fetus is inadvertently sampled twice, are reported to occur in 1% of all CVS procedures in multiples. 21 The risk of sampling errors can be minimized by carefully mapping each fetus and its placenta, and by accurate needle or catheter placement guided by continuous ultrasound. As with amniocentesis, precise mapping is essential in the event that discordant results are obtained. Errors in which tissue from one placenta contaminate a second sample occur in up to 1.6% of cases. 22 The frequency of contamination errors can be minimized by collecting samples near the cord insertion site when placentas are adjacent to one another, avoiding the dividing membrane, and by using both transvaginal and transabdominal approaches in some cases. In as many as 5% of cases, there may be uncertainty as to whether both placentas have been sampled. 17 When this occurs it is important that a second procedure, either a repeat CVS or an amniocentesis in the second trimester, be performed to ensure accurate sampling. In the studies that have evaluated the pregnancy outcomes in twins following CVS, post-procedure loss rates prior to 20 weeks gestation were as high as 4.5% (Table 1) . 23 This loss rate is similar to that reported following CVS in singleton gestations. Interestingly, the pregnancy loss rate in twin gestations after CVS is not significantly higher when compared with the spontaneous loss rate in unsampled twins. Furthermore, the procedure-related loss rate from CVS is similar to the loss rate following second trimester amniocentesis in twin pregnancies.
Both CVS and amniocentesis have been performed in higher-order multiples, however, data regarding the procedure-related risks are limited. It seems reasonable to expect that the technical challenges of performing these procedures, and possibly the procedure-related losses, are directly related to the number of fetuses that require sampling. For these reasons, prenatal diagnosis in higher-order multiple gestations should be performed only by those operators who have significant experience with these procedures.
MANAGEMENT OF DISCORDANT FETAL ABNORMALITIES
When fetal abnormalities are detected in 1 fetus of a multiple gestation, couples can
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choose between expectant management, termination of the entire pregnancy, and selective termination of the abnormal fetus. The goal of selective termination is to prevent the birth of a handicapped child or to minimize the risk to an entire pregnancy from an anomalous fetus while not harming the remaining fetus(es) through miscarriage or premature delivery. Selective termination in multichorionic pregnancies is most commonly performed by fetal intracardiac injection of potassium chloride. In monochorionic pregnancies, this method can result in demise of the co-twin either by transplacental passage of potassium chloride or acute hemodynamic changes in the untreated fetus. A number of methods involving cord ligation and/or coagulation have been described for performing selective termination in monochorionic pregnancies. 24 Experience with these techniques is limited but early reports suggest a higher risk of membrane rupture and pregnancy loss. 25 In a multicenter study of 402 reductions using either intracardiac or intrafunic potassium chloride, the overall rate of pregnancy loss prior to 24 weeks was 7.5%. 26 The pregnancy loss rates based on the gestational age at the time of the procedure were 5.4% performed between 9 and 12 weeks, 8.7% between 13 and 18 weeks, 6.8% between 19 and 24 weeks, and 9.1% when the procedure was performed beyond 25 weeks. 26 These results suggest that the risk of fetal loss is lower when fetal reduction is performed in the first rather than the second trimester, however, other studies have found similar loss rates following multifetal reduction in the first trimester and selective reduction in the second trimester. 27 Studies have been performed evaluating pregnancy loss rates when prenatal diagnosis is combined with multifetal pregnancy reduction. Initially, higher loss rates were reported in patients that underwent amniocentesis after multifetal pregnancy reduction. However, a recent series of 294 patients who underwent multifetal pregnancy reduction, the fetal loss rate in the 127 who subsequently had an amniocentesis in the second trimester was similar to the unsampled group. 28 Similarly, studies have shown that fetal loss rates are not increased in patients who have CVS prior to undergoing multifetal pregnancy reduction. 3 In general, there does not appear to be an increased risk when prenatal diagnosis is performed before or after multifetal pregnancy reduction. The decision to undergo CVS prior to multifetal reduction versus amniocentesis after the reduction can be based on risk assessment. If the risk for aneuploidy is high, CVS may be preferable so that chromosomally normal fetuses can be preserved and selective termination later in gestation can be avoided. However, if the risk for aneuploidy is low, amniocentesis may be preferable because it has a lower risk of sampling errors and is technically easier to perform. Another advantage to performing prenatal diagnosis after multifetal pregnancy reduction is that fewer samples need to be obtained. Given that fetal structural abnormalities are usually diagnosed in the midtrimester, amniocentesis and second trimester selective reduction will still be necessary for some couples and they can be reassured that it is a safe option in multichorionic multiple gestations.
Intrauterine Demise of One Fetus

DIAGNOSIS AND THE IMPORTANCE OF ULTRASOUND
The increasing use of ultrasonography in early pregnancy has demonstrated that the incidence of multiple gestations is higher than previously believed. Twin gestations occur in 12% of all spontaneous conceptions. 29 However, it is estimated that only 50% of twin pregnancies identified in the first trimester will result in two live born infants. 30 While the demise of one fetus of a multiple gestation is common in the first trimester, most patients are asymptomatic or have only slight vaginal spotting following the loss. Fortunately, when demise occurs early in pregnancy, it appears that the prognosis for the surviving fetuses is excellent.
After the first trimester, it is standard practice to follow multiple gestations with serial ultrasounds to evaluate fetal growth and well-being. The majority of intrauterine fetal demises will be diagnosed at the time of routine ultrasound. Excluding early fetal loss, intrauterine demise of one fetus occurs in 5% of twin gestations. 31 It is estimated that there is a three to fourfold increase in intrauterine death with monochorionic twins compared with dichorionic twins. Twins with structural malformations are more likely to die in utero than their anatomically normal cotwins. Intrauterine demise of a single fetus is also common in higher-order multiple gestations, complicating 17% of triplet pregnancies. 32 As in singletons, the etiology of a fetal demise in a multiple gestation is often unknown. Complications unique to multiples that contribute to an increased incidence of fetal demise are twintwin transfusion syndrome in monochorionic pregnancies and cord entanglement in monoamniotic twins. Intrauterine demise of one fetus in a multiple gestation also increases the risk for adverse events in the surviving fetus(es). These adverse events include neurologic injury and mortality in monochorionic twins, and preterm delivery in monochorionic and dichorionic pregnancies. Clinical management of these pregnancies depends on the gestational age, fetal lung maturity, and the detection of other fetal or maternal complications.
MANAGEMENT OF MULTIPLE GESTATIONS COMPLICATED BY FETAL DEMISE
One of the major concerns when fetal death occurs during the second or third trimester of pregnancy is the high incidence of morbidity and mortality in the survivors. In a retrospective analysis of twin pregnancies complicated by the intrauterine death of one twin, 46% of surviving twins experienced major morbidity or mortality. 34 Rydhstrom and Ingemarsson reported a 27% perinatal mortality rate for the remaining twin after antenatal death of its cotwin. 33 In this retrospective study, 4.6% of the surviving twins were handicapped by mental retardation or cerebral palsy at 8 years after birth or later.
More recent prospective studies reported neurologic damage in 5% to 20% of surviving twins, with the greatest potential for injury in monochorionic gestations. 35, 36 Neurologic damage to a surviving twin in a monochorionic pregnancy has been noted to occur with the demise of a cotwin as early as 12 weeks gestation. While the exact mechanism of injury is uncertain, it is thought to be related to the shared vasculature in monochorionic pregnancies. The extent of shared placental vasculature likely influences the degree to which a surviving twin will be affected by demise of its cotwin. There are two main theories regarding the pathophysiology of neurologic injury in surviving mono-chorionic twins. An early theory was that the retained dead fetus generates thromboplastic materials that embolize through placental anastomoses to the surviving twin. 37 A more recent and more widely held theory is that the sudden decrease in blood pressure that occurs at the time of fetal death results in "back-bleeding" from the live twin into the dead twin's vasculature causing transient but severe hypotension and hypoxemia in the surviving fetus. 35 This theory has been supported by the development of anemia in the surviving twins with normal coagulation studies. Given that the changes in blood pressure are likely instantaneous with fetal death, it is not surprising that immediate delivery has not prevented the development of multicystic encephalomalacia in the surviving twin. In dichorionic multiple gestations, the risk of major perinatal morbidity or mortality to the surviving twin appears to be negligible apart from that related to prematurity. In a review of 8 dichorionic twin gestations complicated by single intrauterine death, Fusi and Gordon found no neurologic defects among the survivors. 35 The surviving twin may be protected from neurologic injury because of the rarity of vascular communications in dichorionic gestations. Despite the concern of potential neurologic deficits in the survivors of multiple gestations complicated by a single fetal demise, one of the greatest risks to the remaining live fetuses regardless of chorionicity is prematurity. Overall 50% to 80% of surviving cotwins are delivered prior to term with most due to the complication of preterm labor.
In addition to possible harm to the surviving fetus(es), there is also the potential for maternal consumptive coagulopathy. As in singleton pregnancies with retention of a dead fetus for 4 to 5 weeks, it has been estimated that there is a 25% incidence of maternal disseminated intravascular coagulation when fetal demise occurs in a multiple gestation. However, only a few cases of maternal coagulopathy have been reported under these circumstances and the 25% incidence is likely an overestimation. In a review of 16 pregnancies complicated by intrauterine fetal death of 1 twin, there were no cases of maternal disseminated intravascular coagulation. 35 While transient fibrinsplit product elevation and hypofibrinogenemia have been observed in some twin cases complicated by demise of 1 fetus, medical therapy or intervention was not necessary. 36 Although the maternal risk appears to be low, periodic coagulation profiles are recommended to detect the early development of this complication, including a screen during the intrapartum period.
Regardless of chorionicity, multiple gestations that are complicated by the intrauterine demise of 1 fetus need to be followed closely for evidence of preterm labor. Administration of corticosteroids to enhance fetal lung maturity between 24 and 34 weeks is reasonable given the increased risk. Frequent assessments of fetal well-being and growth are recommended, especially in monochorionic twins. Unfortunately, it is difficult to predict whether the surviving fetus of a monochorionic pregnancy will develop cerebral damage. Serial ultrasounds and magnetic resonance imaging may be useful to detect multicystic encephalomalacia antenatally. When the demise of a monochorionic twin occurs prior to viability, parents should be counseled about the risks of neurologic injury to the surviving cotwin and pregnancy termination should be offered. Although intensive antepartum assessment of multiple pregnancies complicated by intrauterine demise of 1 fetus is required, fetal death should not be the sole indication for delivery. In monochorionic pregnancies with impending demise of 1 twin, preterm delivery may be indicated to prevent neurologic injury to the survivor or to potentially salvage both twins. When demise of 1 twin has already occurred, elective delivery should be considered at 37 weeks or once fetal lung maturity is documented. Cesarean delivery should be reserved for routine obstetric indications as vaginal delivery is not contraindicated in this situation.
Preterm Premature Rupture of the Membranes
Preterm premature rupture of membranes (PPROM) occurs in one quarter to one third of all preterm births making it a leading cause of infant morbidity and mortality. While there is extensive literature on the clinical course of singleton pregnancies complicated by PPROM, there is limited data on PPROM in multiples. As a result, the optimal management of this complication in multiple gestations is not clear and clinical decisions are compounded by the presence of one or more fetuses which still have intact membranes. The ideal approach to PPROM in multiple gestations involves a balancing of maternal and fetal risks.
DIAGNOSIS
The incidence of PPROM in multiple gestations is two times that of singleton pregnancies. 38 In a retrospective review of multiples between 19 and 36 weeks' gestation, PPROM complicated 7.4% of twin pregnancies compared with 3.7% singletons. 38 The incidence of PPROM in triplets was similar to that in twins at 7.4%. PPROM in the midtrimester of pregnancy also occurs more frequently in twins (1.4%) compared with singletons (0.5%). In the majority of cases, rupture occurs in the presenting sac, and the diagnosis is easily confirmed on clinical evaluation of vaginal pooling, ferning, and Nitrazine paper testing. The diagnosis can be more difficult with PPROM of the nonpresenting sac; as the leakage of fluid per vagina may be intermittent. The exact incidence and clinical course of PPROM in a nonpresenting sac is unknown. Whether rupture of the nonpresenting sac is limited to the performance of invasive procedures such as amniocentesis and chorionic villus sampling is not known. Information on the incidence of PPROM in multiples based on chorionicity is also limited. A complication that appears to be unique to monochorionic, diamniotic twin pregnancy is rupture of the dividing membrane. 39 Rupture of the separating membrane can result in a twin pair sharing a sac with all the risks associated with monoamniotic twins. In some cases, this complication follows an invasive procedure such as an amniocentesis. However, in some cases, there is no precipitating event to explain the finding of a monoamniotic gestation that was previously diamniotic. Although the exact incidence is unknown, spontaneous rupture of the separating membrane is likely a rare event. In addition to invasive procedures, rupture of the separating membrane in a multiple gestation may be the result of infection, actions of the fetuses, or developmental disturbances. 39 The resultant monoamniotic pregnancies have been complicated by preterm delivery, with an average gestational age at delivery of 29 weeks, and an overall perinatal mortality of 44%.
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LATENCY
The latency period between rupture of the membranes and delivery of conservatively managed twins and singletons is similar. For twin gestations with PPROM between 19 and 36 weeks, Mercer et al reported a median latency of 1.1 days. 38 Of the 91 twin pairs, 64% delivered within 48 hours, and 91% delivered within 7 days of membrane rupture. These observations were not significantly different from those observed in singleton gestations, which had a median latency of 1.7 days, with 90% delivered at 7 days. 38 In a comparison of 116 twins with PPROM to matched singleton controls, the median latency period in twins was 11.4 hours compared with 19.5 hours in singletons. 40 However, the shorter latency in twins was of little clinical significance as the proportion of twins and singletons delivered at 48 hours and 7 days were similar.
As in singleton pregnancies, the length of the latency period in multiple gestations is related to the gestational age at the time of membrane rupture. Latency is significantly prolonged when PPROM occurs prior to 30 weeks gestation. In a comparison of 48 twins and 131 singletons, the latency periods were similar when PPROM occurred prior to 30 weeks gestation (4.8 days versus 5.6 days). 41 However, when PPROM occurred after 30 weeks, latency for twins was significantly shorter than that of singletons (2.5 days versus 3.7 days). In a matched comparison of 116 twins and 116 singletons with PPROM, a significantly shorter latency period was found in twins overall (11.4 hours versus 19.5 hours) and when PPROM occurred prior to 30 weeks (27.6 hours versus 75.1 hours). 40 Despite the shorter latency for twins compared with singletons, there were no significant differences in neonatal outcomes between the 2 groups.
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MANAGEMENT OF PPROM IN MULTIPLES
Both singleton and twin pregnancies complicated by PPROM are at increased risk for infection, cord accidents, and abruptio placentae. Mercer et al, found no significant differences in the incidence of amnionitis (15% versus 23%), cord prolapse (4% versus 2%), or placental abruption (1% versus 6%) between singleton and twin pregnancies. 37 Overall, there are no differences in perinatal morbidity or mortality between singletons and twins with PPROM. 40, 41 However, significant differences in neonatal morbidity have been reported between the presenting and nonpresenting fetuses. 38 In twin pregnancies complicated by PPROM, the nonpresenting twin is at increased risk for respiratory distress syndrome (20.9% versus 7.1%) and prolonged oxygen therapy (43.6% versus 22.6%) when compared with the presenting twin. 38 It is unknown whether this reflects accelerated fetal lung maturity after PPROM in the presenting twin or an inherent relative immaturity in the nonpresenting twin. The finding of increased respiratory morbidity and lower Apgars in the nonpresenting twins did not appear to be related to the route or mode of delivery. 38 Despite PPROM of the presenting sac, there were no significant differences in infectious morbidity between the presenting and nonpresenting twins. 38 Based on these findings, patients should be counseled that the nonpresenting fetus appears to be at higher risk for respiratory complications.
The most critical aspect to consider in the management of PPROM in multiple gestations is the gestational age at the time of membrane rupture. It is important to weigh the risks of prematurity versus the risks of infection and the potential adverse effects of oligohydramnios. Infectious complications from PPROM may affect the mother, the fetus in the ruptured sac, as well as adjacent fetuses with intact membranes. The risks of oligohydramnios pertain primarily to the fetus in the ruptured sac and these risks are dependent on gestational age and the amount of remaining amniotic fluid. For example, oligohydramnios early in gestation may be associated with the development of pulmonary hypoplasia, skeletal deformities, and amniotic band syndrome.
PPROM can be classified as previable (prior to 23 completed weeks gestation), remote from term (23 to 31 weeks gestation), and near term (32 to 36 weeks gestation). The contemporary management of singletons with PPROM is well established and can be applied to multiple gestations (Fig.  1) . 42 Regardless of gestational age, once the diagnosis of PPROM is confirmed, digital examinations of the cervix should be avoided to increase latency and decrease infectious morbidity. Visualization of the cervix by sterile speculum should be performed at which time appropriate cultures can be obtained. Patients should then be carefully evaluated for any evidence of advanced labor, infection, placental abruption, and nonreassuring fetal status. Apart from nonreassuring fetal status at a previable gestational age, the development of these complications warrants expeditious delivery.
The management of multiple gestations with PPROM near term is similar to that of singletons. When PPROM occurs after 34 weeks, the perinatal complications related to prematurity are outweighed by the risks of chorioamnionitis and fetal loss due to cord compression, and therefore delivery is recommended. 42 Antibiotic prophylaxis for group B Streptococcus should be given if culture results are not available or broadspectrum antibiotics if there is any evidence of intrauterine infection. PPROM in multiple gestations between 32 to 34 weeks warrants delivery if fetal lung maturity is documented on vaginal pool amniotic fluid or from amniocentesis on the ruptured fetus or from the unruptured fetus(es). If fetal lung maturity studies are negative, discordant, or if fluid is not available from all fetuses then there is still a risk of gestational-age dependent respiratory morbidity. In these cases, conservative management with close fetal surveillance and maternal monitoring as an inpatient is recommended. Adjunctive antibiotic therapy is recommended to treat or prevent ascending infection to prolong the pregnancy. 42 A single course of antenatal corticosteroids is also recommended to decrease the incidence of respiratory distress syndrome and intraventricular hemorrhage in multiples with documented fetal lung immaturity beyond 32 weeks. Tocolysis is not typically used at these gestational ages because the risk of significant perinatal morbidity is low. 42 In the absence of labor, placental abruption, nonreassuring fetal testing, or chorioamnionitis, delivery should be considered once 34 weeks of gestation is reached.
Similarly, the management of multiples with PPROM remote from term parallels that of singletons. When PPROM occurs between 23 and 31 weeks, conservative management is recommended to prolong the pregnancy since delivery before 32 weeks is associated with significant risks of neonatal morbidity and mortality. 42 Inpatient fetal and maternal surveillance, a single course of antenatal corticosteroids, and antibiotics to prolong latency are all recommended. 42 Ideally, conservative management of multiple gestations complicated by PPROM should be performed at centers that are capable of providing immediate cesarean deliveries and appropriate neonatal care. If necessary, patients should be transferred early in the course of management to avoid emergent transfer in the event that complications develop. Although data regarding the role of tocolysis in multiple gestations with PPROM are lacking, the use of prophylactic tocolytics to prolong pregnancy and allow time for the benefits of corticosteroids and antibiotics is reasonable in some cases. Again, in the absence of labor, placental abruption, nonreassuring fetal testing, or chorioamnionitis, delivery should be considered once 34 weeks of gestation is achieved. In the absence of additional complications, delivery between 32 and 34 weeks is reasonable with PPROM if fetal lung maturity is documented for each fetus.
In contrast to PPROM remote from or near term, strategies for managing PPROM in multiple gestations at previable gestational ages are less uniform than that for singleton pregnancies. Currently, there are no data with which to make specific recommendations regarding management in these cases. Options for previable PPROM range from expectant management to termination of the entire pregnancy. Patients should be counseled about the maternal and fetal risks and benefits of expectant management versus termination, and consent for any management plan should be obtained. If termination is declined, outpatient management after an initial observation period to exclude infection or abruption is a reasonable option. As in singleton pregnancies with PPROM, infection must be excluded and prompt delivery undertaken for any evidence of intrauterine infection. Weekly visits to assess maternal and fetal status should be performed until fetal viability is reached. At this time, patients are usually readmitted to hospital for closer maternal and fetal surveillance. Psychologic support should be made available for patients and their families when faced with the difficult management choices and decisions dealing with PPROM in multiple gestations at previable gestational ages. In addition to expectant management and termination of the entire pregnancy, investigational strategies in multichorionic pregnancies with previable PPROM may be considered including selective reduction of the fetus in the ruptured sac or preterm delivery of this fetus followed by aggressive attempts to retain the remaining fetuses.
Selective reduction of a previable fetus following rupture of membranes in a multiple gestation was first described by Dorfman et al 43 This approach was based on the assumption that the risk of ascending infection would be reduced if the continuous leakage of amniotic fluid was eliminated and that a lower risk of infection would lead to an improved chance of the unruptured cotwin progressing to viability. In a comparison of expectant management versus selective reduction in multichorionic multiple pregnancies between 13 and 20 weeks gestation with PPROM, Catte et al reported on the outcome of 12 pregnancies. 44 Nine patients were managed expectantly without antibiotics or tocolytics. Selective reduction was performed in 3 cases within 3 days of rupture, followed by a 5-day course of antibiotics. Weekly steroids were administered beginning at 24 weeks gestation. The mean interval between membrane rupture and delivery in the expectantly managed group was 7.4 weeks with only 3 survivors. In the selective reduction group, 2 of the 3 pregnancies progressed beyond 33 weeks. Although the numbers are small and further research is needed, selective reduction of a previable fetus in a ruptured sac of a multichorionic gestation may be a reasonable option in carefully selected cases.
Another approach to prolonging pregnancy in cases of previable PPROM is the use of tocolytic therapy, antibiotics, and cervical cerclage in a delayed internal delivery. In a series of 8 multifetal gestations complicated by PPROM before 24 weeks gestation, Arias et al reported on efforts to delay delivery of the retained fetuses after delivery of the fetus in the ruptured sac. 45 Broadspectrum antibiotics were administered before and after delivery of the presenting fetus, either spontaneously or by induction, the umbilical cord was ligated as high as possible within the cervical canal. Tocolytics were given for uterine contractions and a cerclage was placed once contractions ceased. Prophylactic tocolysis with indomethacin was then administered for 48 to 72 hours and antibiotics were continued for 1 week, at which time patients were discharged to home. The mean interval time between delivery of the first and remaining fetuses was 48 days. Although this approach delayed delivery of the retained fetuses, subsequent reports have suggested less favorable results. 45 Based on available data, an aggressive strategy of tocolysis and cerclage to promote delayed interval delivery in multiple gestations complicated by previable PPROM should be considered investigational and associated with potentially significant maternal risks.
The optimal management of previable PPROM in multiple gestations remains unclear. Conservative management results in an extremely high pregnancy loss rate and exposes the mother to the risks of infection and complications of prolonged bed rest. In addition, pregnancies that progress to fetal viability are still subject to high neonatal morbidity and mortality from oligohydramnios, infection, and prematurity. Given the complexities of previable PPROM, an individualized approach is recommended. In certain circumstances, termination of the entire pregnancy may be the best approach. While aggressive interventions such as tocolysis and cerclage after previable PPROM may be considered, the benefits of these techniques need to be adequately demonstrated before they become routine. This will be discussed more in the next section. Similarly selective reduction, which might provide better outcomes than expectant management, requires further study.
Preterm Delivery of One Fetus
SIMPLE DIAGNOSIS WITH SERIOUS IMPLICATIONS
One of the most common and serious complications of multiple gestations is preterm delivery. In the majority of cases, the remaining fetus(es) delivers soon after the presenting fetus is born. However, in rare circumstances, preterm delivery of 1 fetus may occur without spontaneous delivery of the remaining fetus(es). This unique event raises the possibility of prolonging a pregnancy to a more advanced gestational age before delivering the remaining fetus(es). The current literature on delayed interval delivery in multiple gestations is limited and subject to bias of only reporting favorable outcomes. In a series of 24 consecutive twins and triplets from a single practice that were candidates for delayed delivery, a uniform approach of tocolysis, antibiotics, and cerclage resulted in a mean interval delivery time of 36 days, with a range of 3 to 123 days. 46 While there were no survivors in the 16 firstborn fetuses that delivered prior to 24 weeks gestation, 8 of the 18 retained fetuses in this group survived. 46 In the 9 pregnancies in which the first-born delivered after 24 weeks, 4 infants survived. Of the 9 retained fetuses in this group, all survived. Overall, the perinatal mortality rate of first-born infants regardless of gestational age was 84%. The perinatal mortality rate of the infants born after delayed interval delivery was significantly less at 37%.
CANDIDATES FOR DELAYED INTERVAL DELIVERY
Attempts to delay delivery of the remaining fetus(es) following the birth of the presenting fetus in a multiple gestation should only be undertaken in the absence of any maternal or fetal indications for delivery (Table
Unique Obstetrical Complications in Multiples
2). Consideration should be given to the number of remaining fetuses, the gestational age at the time of delivery of the first fetus, placental chorionicity, evidence of chorioamnionitis, rupture of membranes of the retained fetus(es), placental abruption, and maternal and fetal well-being. Delayed interval delivery has been reported primarily in twin gestations, however, delayed delivery in higher-order multiples has been attempted. In a 1999 review of interval deliveries in multiple gestations, delayed interval delivery was tried in 48 cases of twins, 12 cases of triplets, 2 cases of quadruplets, and a single case of quintuplets. 47 Despite the limited data on higher-order multiples, attempts to delay delivery are reasonable in the absence of contraindications irrespective of the starting number of fetuses.
The gestational age at the time of delivery of the first fetus should be at least 16 to 18 weeks before delayed interval delivery is considered. In general, delayed delivery is not recommended beyond 28 weeks, as the risks of prolonging the pregnancy likely outweighs the potential benefit. Therefore, potential candidates for interval delivery are those who deliver the first fetus late in the second trimester or early in the third trimester. It has also been recommended that delayed interval delivery be attempted only in multiples where each fetus has its own placenta. 45 The concern is that the shared placental circulation of a monochorionic twin gestation predisposes the retained twin to neurologic injury due to hypotensive ischemia at the time of death of the cotwin. 35 However, normal neurologic development has been reported in the surviving cotwin of a monochorionic-diamniotic pregnancy in which a single fetal demise occurred at 20 weeks gestation with delivery of the dead fetus at 27 weeks, followed by a successful delayed birth of a healthy cotwin 42 days later. 48 There has also been a case report of delayed interval delivery in a monochorionic twin gestation involving a live born fetus delivered at 24 weeks gestation with delivery of the retained co-twin 10 weeks later. 49 Both infants survived without major sequelae. It is possible that umbilical cord ligation at the time of delivery of the first twin of a monochorionic pair might prevent the hemodynamic changes that are believed to be implicated in the neurologic injury of the cotwin. Regardless of the gestational age at the time of delivery of the first twin in a monochorionic pregnancy, patients and their families should still be counseled about the potential risk of neurologic injury to the retained twin.
Intrauterine infection is a common cause of preterm delivery and attempts at delayed interval delivery are contraindicated if there is any evidence of chorioamnionitis. Furthermore, the development of chorioamnionitis is one of the most common reasons for discontinuing attempts at delayed delivery. 45 While there have been rare cases with successful perinatal outcomes in which chorioamnionitis was treated with antibiotics, maternal sepsis has occurred during attempts at delayed interval delivery. Despite isolated case reports of successful interval deliveries when chorioamnionitis is suspected, such a strategy cannot be recommended given the risks of both fetal and maternal morbidity. Amniocentesis to assess for infection in the amniotic fluid of the fetus or fetuses that are candidates for retention can be considered. If not documented previously, a detailed anatomic survey of the remaining fetus(es) is warranted as this may influence a families' decision to pursue aggressive management. In addition, aggressive attempts to prolong pregnancy should not be undertaken 
APPROACH TO DELAYED INTERVAL DELIVERY
If a delayed interval delivery is attempted, it is important to obtain informed consent regarding the potential risks and benefits. Counseling should include the benefits of successfully prolonged pregnancy, specifically that even modest gains during critical gestational ages, can lead to a significant decrease in neonatal morbidity and mortality. However, patients should also be informed of the risk of delivering a baby after a short interval with severe morbidity related to prematurity, instead of delivering a previable fetus that will not survive. Ideally, candidates for delayed interval delivery should be identified before the first fetus is born to allow appropriate time for counseling and preparing a management strategy. After delivery of the presenting fetus, the umbilical cord should be ligated with an absorbable suture, such as Vicryl (Ethicon, Inc., Somerville, NJ) as high as possible inside the cervix. In women with a pregnancy in each horn of a didelphys uterus, the placenta can be successfully removed after delivery of 1 twin, leaving the remaining twin and placenta undisturbed. Antenatal corticosteroids are generally recommended for patients at risk for preterm delivery between 24 and 34 weeks of gestation with intact membranes or between 24 and 32 weeks of gestation for patients with ruptured membranes. Similar guidelines should be applied to cases of delayed interval delivery in multiple gestations. Patients with a previable delivery should receive a single course of steroids once the retained fetus(es) reach 24 weeks of gestation. Although repeat courses of corticosteroids are not used routinely, a rescue course of steroids may be considered if the interval time is prolonged and the first course was given at 24 weeks' gestation. The use of prophylactic antibiotics is also controversial. The rationale is to prevent ascending infection, thereby prolonging the pregnancy for the remaining fetus(es). Although the data are limited, routine cultures of the vagina and cervix should be obtained. If prophylactic antibiotics are used, they should be broad-spectrum to cover the variety of bacteria that have been isolated from the cervix, placenta, and amniotic fluid in cases of delayed interval delivery. Once culture results are available, antibiotics can be changed to provide more specific coverage. While the benefits of prophylactic antibiotics in cases of delayed interval delivery are uncertain, a short course of broad-spectrum antibiotics seems reasonable. Similarly, the role of tocolysis in delayed interval deliveries is uncertain. There is variation in the literature regarding the choice of tocolytic, when tocolysis should be started, and for how long patients should be treated. Indomethacin may mask the clinical signs of chorioamnionitis and therefore, is not the ideal choice for tocolysis in cases of delayed interval delivery. While no single strategy of tocolysis has been proven to be beneficial, it is reasonable to use short-term tocolysis after delivery of the first fetus.
The benefit of cerclage placement in multifetal pregnancies after delivery of 1 fetus has also not been conclusively proven. It has been advocated that a cerclage will close the cervix and decrease the risks of ascending infection. In contrast, the placement of a cerclage may increase the risk of initiating labor or developing chorioamnionitis. Cervical cerclage has also been used selectively in cases where the cervix remains dilated after delivery of the presenting fetus. In a review of 20 patients who had a cerclage after delivery of the first fetus compared with 21 patients who did not showed no difference in pregnancy prolongation. 50 If a cerclage is considered an option, it is recommended that it be done soon after delivery of the first fetus as more favorable outcomes have been observed when the cerclage is placed within 2 hours. While most cerclages are performed using the McDonald technique, a twocerclage technique using a Shirodkar and McDonald cerclage may be used to support the entire length of the cervix. Regardless of the elapsed time from delivery of the first fetus or the technique used, it is important that uterine contractions have ceased, placental abruption has been excluded, and the well-being of the retained fetus(es) and mother have been confirmed before a cerclage is attempted.
Whether patients attempting a delayed delivery require hospitalization until all deliveries have occurred is an open question. Advantages of outpatient management are a more familiar and comfortable environment for the patient and an overall reduction in hospital costs. All patients who have delivered one fetus of a multiple gestation should be hospitalized for an initial period of observation to monitor for preterm labor, chorioamnionitis, nonreassuring fetal status, or placental abruption. Fetal assessment of the remaining fetus(es) will vary depending on gestational age but may include intermittent heart rate auscultation, nonstress tests, or biophysical profiles. An individualized plan based on gestational age, degree of cervical dilation, compliance with modified bed rest, and social support should be considered before outpatient management is pursued.
In a review of 35 pregnancies in which the first fetus was delivered prior to 24 weeks, the mean interval delay was longer in those treated with antibiotics, tocolytics and cerclage 18 compared with antibiotics alone, 3 cerclage alone, 2 or antibiotics and tocolytics. 11, 47 However, the numbers were small, the ranges were wide, and statistically there was no difference between the 4 groups. Overall, 24 of the 70 fetuses survived. Patients who are offered an attempt at delayed interval delivery should be carefully selected and counseled about the risks and benefits of this approach. At the present time, the optimal strategy for a delayed interval delivery is unknown. Management of multiple gestations following the preterm delivery of one fetus must be individualized according to the condition of the mother, the remaining fetus(es), and the wishes of the woman and her family.
Summary
Multiple gestations pose a number of unique challenges when obstetric complications occur. The diagnosis and management of fetal abnormalities, intrauterine demise, preterm premature rupture of the membranes, and preterm delivery are confounded by the presence of additional fetuses in utero. These complex clinical circumstances demand thorough counseling of the patient and her family as well as care by physicians with expertise in the management of multiple gestations.
